Development and Validation of an MRI-Based Radiomics Signature for the Preoperative Prediction of Lymph Node Metastasis in Bladder Cancer

被引:115
作者
Wu, Shaoxu [1 ]
Zheng, Junjiong [1 ]
Li, Yong [2 ]
Wu, Zhuo [2 ]
Shi, Siya [2 ]
Huang, Ming [1 ]
Yu, Hao [1 ]
Dong, Wen [1 ]
Huang, Jian [1 ]
Lin, Tianxin [1 ,3 ]
机构
[1] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Urol, Guangdong Prov Key Lab Malignant Tumor Epigenet &, Guangzhou, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Radiol, Guangzhou, Guangdong, Peoples R China
[3] State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China
来源
EBIOMEDICINE | 2018年 / 34卷
关键词
Urinary bladder neoplasms; Lymphatic metastasis; Radiomics; Nomogram; POSITRON-EMISSION-TOMOGRAPHY; RADICAL CYSTECTOMY; NEOADJUVANT CHEMOTHERAPY; PROSPECTIVE MULTICENTER; LYMPHADENECTOMY; DISSECTION; CARCINOMA; OUTCOMES; STAGE; MORTALITY;
D O I
10.1016/j.ebiom.2018.07.029
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Preoperative lymph node (LN) status is important for the treatment of bladder cancer (BCa). However, a proportion of patients are at high risk for inaccurate clinical nodal staging by current methods. Here, we report an accurate magnetic resonance imaging (MRI)-based radiomics signature for the individual preoperative prediction of LN metastasis in BCa. Methods: In total, 103 eligible BCa patients were divided into a training set (n=69) and a validation set (n=34). And 718 radiomics features were extracted from the cancerous volumes of interest (VOIs) on T2-weighted MRI images. A radiomics signature was constructed using the least absolute shrinkage and selection operator (LASSO) algorithm in the training set, whose performance was assessed and then validated in the validation set. Stratified analyses were also performed. Based on the multivariable logistic regression analysis, a radiomics nomogram was developed incorporating the radiomics signature and selected clinical predictors. Discrimination, calibration and clinical usefulness of the nomogram were assessed. Findings: Consisting of 9 selected features, the radiomics signature showed a favorable discriminatory ability in the training set with an AUC of 0.9005, which was confirmed in the validation set with an AUC of 0.8447. Encouragingly, the radiomics signature also showed good discrimination in the MRI-reported LN negative (cN0) subgroup (AUC, 0.8406). The nomogram, consisting of the radiomics signature and the MRI-reported LN status, showed good calibration and discrimination in the training and validation sets (AUC, 0.9118 and 0.8902, respectively). The decision curve analysis indicated that the nomogram was clinically useful. Interpretation: The MRI-based radiomics nomogram has the potential to be used as a non-invasive tool for individualized preoperative prediction of LN metastasis in BCa. External validation is further required prior to clinical implementation. (c) 2018 The Authors. Published by Elsevier B.V.
引用
收藏
页码:76 / 84
页数:9
相关论文
共 43 条
  • [11] Lymph Node Dissection Technique Is More Important Than Lymph Node Count in Identifying Nodal Metastases in Radical Cystectomy Patients: A Comparative Mapping Study
    Dorin, Ryan P.
    Daneshmand, Siamak
    Eisenberg, Manuel S.
    Chandrasoma, Shahin
    Cai, Jie
    Miranda, Gus
    Nichols, Peter W.
    Skinner, Donald G.
    Skinner, Eila C.
    [J]. EUROPEAN UROLOGY, 2011, 60 (05) : 946 - 952
  • [12] Radiomics: Images Are More than Pictures, They Are Data
    Gillies, Robert J.
    Kinahan, Paul E.
    Hricak, Hedvig
    [J]. RADIOLOGY, 2016, 278 (02) : 563 - 577
  • [13] Role of fluorodeoxyglucose positron emission tomography (FDG PET)-computed tomography (CT) in the staging of bladder cancer
    Goodfellow, Henry
    Viney, Zaid
    Hughes, Paul
    Rankin, Sheila
    Rottenberg, Giles
    Hughes, Simon
    Evison, Felicity
    Dasgupta, Prokar
    O'Brien, Timothy
    Khan, Muhammad Shamim
    [J]. BJU INTERNATIONAL, 2014, 114 (03) : 389 - 395
  • [14] International Phase III Trial Assessing Neoadjuvant Cisplatin, Methotrexate, and Vinblastine Chemotherapy for Muscle-Invasive Bladder Cancer: Long-Term Results of the BA06 30894 Trial
    Griffiths, Gareth
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (16) : 2171 - 2177
  • [15] Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer
    Grossman, HB
    Natale, RB
    Tangen, CM
    Speights, VO
    Vogelzang, NJ
    Trump, DL
    White, RWD
    Sarosdy, MF
    Wood, DP
    Raghavan, D
    Crawford, ED
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (09) : 859 - 866
  • [16] Evaluation of different lymph node (LN) variables as prognostic markers in patients undergoing radical cystectomy and extended LN dissection to the level of the inferior mesenteric artery
    Jensen, Jorgen B.
    Ulhoi, Benedicte P.
    Jensen, Klaus M. -E.
    [J]. BJU INTERNATIONAL, 2012, 109 (03) : 388 - 393
  • [17] Bladder cancer
    Kamat, Ashish M.
    Hahn, Noah M.
    Efstathiou, Jason A.
    Lerner, Seth P.
    Malmstrom, Per-Uno
    Choi, Woonyoung
    Guo, Charles C.
    Lotan, Yair
    Kassouf, Wassim
    [J]. LANCET, 2016, 388 (10061) : 2796 - 2810
  • [18] Precystectomy nomogram for prediction of advanced bladder cancer stage
    Karakiewicz, Pierre I.
    Shariat, Shahrokh F.
    Palapattu, Ganesh S.
    Perrotte, Paul
    Lotan, Yair
    Rogers, Craig G.
    Amiel, Gilad E.
    Vazina, Amnon
    Gupta, Amit
    Bastian, Patrick J.
    Sagalowsky, Arthur I.
    Schoenberg, Mark
    Lerner, Seth P.
    [J]. EUROPEAN UROLOGY, 2006, 50 (06) : 1254 - 1262
  • [19] The Impact of Lymphadenectomy and Lymph Node Metastasis on the Outcomes of Radical Cystectomy for Bladder Cancer
    Karl, Alexander
    Carroll, Peter R.
    Gschwend, Juergen E.
    Knuechel, Ruth
    Montorsi, Francesco
    Stief, Christian G.
    Studer, Urs E.
    [J]. EUROPEAN UROLOGY, 2009, 55 (04) : 826 - 835
  • [20] Assessing the calibration of mortality benchmarks in critical care: The Hosmer-Lemeshow test revisited
    Kramer, Andrew A.
    Zimmerman, Jack E.
    [J]. CRITICAL CARE MEDICINE, 2007, 35 (09) : 2052 - 2056